Reprint

Commemorative Issue Celebrating the 20th Anniversary of the Alzheimer’s Foundation of America: Understanding and Treating Alzheimer’s Disease

Edited by
August 2024
198 pages
  • ISBN978-3-7258-1967-6 (Hardback)
  • ISBN978-3-7258-1968-3 (PDF)

This is a Reprint of the Special Issue Commemorative Issue Celebrating the 20th Anniversary of the Alzheimer’s Foundation of America: Understanding and Treating Alzheimer’s Disease that was published in

Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects the lives of millions of people and their families around the globe. It results in a relentless decline in cognitive function, loss of judgment, change in personality, and neuropsychiatric and behavioral symptoms. Pathologic features characteristic of AD are deposition in the brain of two types of misfolded proteins: β-amyloid in the form of extracellular plaques and tau protein in the form of intracellular neurofibrillary tangles. The causal mechanisms of AD are likely multi-factorial but are not yet completely understood. While we are making inroads, especially in the development of more accurate biomarkers for diagnosis, there is no curative treatment.  The following compilation delves into the clinical and pathophysiologic aspects of AD while also addressing standard and cutting-edge treatments. Lifestyle and diet as modifiable risk factors are discussed while social and caregiver impact are given much-needed attention. The expert authors bring their unique insights and perspectives to one of the major health challenges of our time. This work serves as a repository for our current state of knowledge in the field of AD and as a resource for both health professionals and the general public.  

Format
  • Hardback
License and Copyright
© 2024 by the authors; CC BY-NC-ND license
Keywords
Alzheimer’s disease; primary care physicians; dementia; knowledge and attitude; early diagnosis and management; barriers to diagnosis; Alzheimer’s disease; biomarkers; plasma; phospho-tau; amyloid; blood; neurofilament light; positron emission tomography; magnetic resonance imaging; Alzheimer’s disease; plant-based diet; B vitamins; antioxidants; vitamin K; fiber; cognition; dementia; Alzheimer’s disease; big data; neurophysiology; imaging; biomarkers; Alzheimer’s disease (AD); telemedicine; COVID-19; World Health Organization (WHO); Alzheimer’s disease; depression; anxiety; caregiver burden; traditional ideologies; Alzheimer’s disease; amyloid; inflammation; dementia; drug therapy; diet; lifestyle; feature selection; diagnostic algorithm; Electrovestibulography; Alzheimer’s disease; cerebrovascular pathology; gamma-aminobutyric acid; dementia; frailty; caregiver burden; behavioral and psychological symptoms; neuropsychiatric symptoms; race; dementia grief; family caregiver; depressive symptoms; caregiver strain; social support; n/a

Related Books

October 2019

Molecular Mechanism of Alzheimer's Disease

Biology & Life Sciences
August 2023

Molecular Research of Alzheimer's Disease

Medicine & Pharmacology
February 2023

Amyloid-β

Biology & Life Sciences
February 2021

Novel Biomarkers in Alzheimer’s Disease

Biology & Life Sciences
...
January 2022

Genetics of Alzheimer's Disease

Biology & Life Sciences